Ranbaxy To Announce New Drug Development Tie-Up In May

NEW DELHI - India's top generic drug firm Ranbaxy Laboratories expects to announce a new tie up with a large multinational drug firm in May to develop new chemical entities at its recently spun-off Life Science Research unit similar to a current deal with GlaxoSmithKline inked in 2003 and expanded last year, the company's chief executive said